Showing results (1581-1590 of 1,870) with videos related to

Sort By:
Pageof 187
Journal of Neural Engineering|October 19, 2021
Light-weight electrophysiology hardware and software platform for cloud-based neural recording experimentsKateryna Voitiuk, Jinghui Geng, Matthew G Keefe, et al.
Leukemia & Lymphoma|July 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial designKristine Broglio, Lale Kostakoglu, Carol Ward, et al.
Cardiovascular Diabetology|February 15, 2026
Epicardial fat remodeling in end-stage heart failure with reduced ejection fractionMaciej Mączewski, Marta Załęska-Kocięcka, Maksymilian Nowakowski, et al.
Nature Communications|March 17, 2015
Sub-nanosecond signal propagation in anisotropy-engineered nanomagnetic logic chainsZheng Gu, Mark E Nowakowski, David B Carlton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research StatementRamya Thota, Patricia A Hurley, Therica M Miller, et al.
Ecology Letters|February 4, 2021
Preserving 40% forest cover is a valuable and well-supported conservation guideline: reply to Banks-Leite et alVíctor Arroyo-Rodríguez, Lenore Fahrig, James I Watling, et al.
Leukemia & Lymphoma|February 9, 2023
Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphomaHoa Van Le, Kim Van Naarden Braun, Grzegorz S Nowakowski, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2024
Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System ProphylaxisIzel Okcu, Yucai Wang, Allison M Bock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical EfficacyJennifer R Diamond, Valentina Boni, Emerson Lim, et al.
Blood Cancer Journal|July 18, 2021
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab eraArushi Khurana, Raphael Mwangi, Stephen M Ansell, et al.
Pageof 187